News & Press Releases

Mintz is pleased to announce that Danielle Frappier has joined as a Member of the Technology, Communications & Media (TechComm) Practice in the firm’s Washington, DC office. A communications and technology regulatory lawyer with nearly 25 years of experience, Danielle has represented entities across the telecommunications ecosystem, focusing on the intersection of new technologies and traditional regulatory schemes and broadband funding programs.

Mintz announces that Daniel Cowan has joined as a Private Equity Member in the firm’s Boston office. Dan represents private equity funds, portfolio companies, strategic investors, and asset managers in complex business transactions and general corporate matters. He focuses his practice on middle-market deals involving the retail and consumer products, financial services, technology, and health care sectors.

Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.

Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer. 

Mintz advised Greater Asia Pacific, a Hong Kong holding company, in the sale of the controlling interest in Microtek Product Services Co. Ltd. to Centre Testing International Group Co., Ltd. (CTI), a publicly traded Chinese company in the lab tasting space.  

Mintz advised Relation, an industry leader in deploying computation and experimentation to drug discovery, on an equity investment of $15 million from GSK in connection with two simultaneous strategic collaborations with GSK, a global biopharma company. The collaborations are aimed at advancing the development of novel therapeutics for fibrotic diseases and osteoarthritis – conditions which affect millions worldwide and which currently have few treatments addressing their root causes.